March 2, 2020 / 10:11 AM / a month ago

BRIEF-AstraZeneca Completes Divestment With Atnahs Pharma For Hypertension Medicines

March 2 (Reuters) - AstraZeneca PLC:

* COMPLETES DIVESTMENT AGREEMENT WITH ATNAHS PHARMA FOR ESTABLISHED HYPERTENSION MEDICINES

* HAS RECEIVED A PAYMENT OF $350M FROM ATNAHS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below